Anna Bal‐Price

European Commission — Belgium

Neuroscience · Life Sciences

45h-index6.8kcitations104works1.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Anesthesia and Neurotoxicity Research(32), Animal testing and alternatives(23), Neuroscience and Neuropharmacology Research(19), Pesticide Exposure and Toxicity(15), Health and Medical Research Impacts(10)

Publications104 total

The alarming consequences of workforce reductions at the FDA, EPA, NIH and CDC in the United States
Archives of Toxicology·2025Open Access
The Alarming Consequences of Workforce Reductions at the FDA, EPA, NIH and CDC in the United States
Environmental Toxicology and Pharmacology·2025Open Access
The Alarming Consequences of Workforce Reductions at the FDA, EPA, NIH and CDC in the United States
Toxicology Letters·2025
The Alarming Consequences of Workforce Reductions at the FDA, EPA, NIH and CDC in the United States
Toxicology·2025
The Alarming Consequences of Workforce Reductions at the FDA, EPA, NIH and CDC in the United States☆
Current Opinion in Toxicology·2025Open Access
The Alarming Consequences of Workforce Reductions at the FDA, EPA, NIH and CDC in the United States
Computational Toxicology·2025Open Access
The Alarming Consequences of Workforce Reductions at the FDA, EPA, NIH and CDC in the United States
Reproductive Toxicology·2025Open Access
The Alarming Consequences of Workforce Reductions at the FDA, EPA, NIH and CDC in the United States
Regulatory Toxicology and Pharmacology·2025
Developmental neurotoxicity (DNT): A call for implementation of new approach methodologies for regulatory purposes: Summary of the 5th International Conference on DNT Testing
ALTEX·2025· 1 citedOpen Access
The Alarming Consequences of Workforce Reductions at the FDA, EPA, NIH and CDC in the United States
ALTEX·2025Open Access
Mapping out strategies to further develop human-relevant, new approach methodology (NAM)-based developmental neurotoxicity (DNT) testing
ALTEX·2025· 4 citedOpen Access
The Alarming Consequences of Workforce Reductions at the FDA, EPA, NIH and CDC in the United States*
NAM journal.·2025Open Access
S29-02 Development of AOP-informed IATA for developmental neurotoxicity (DNT) risk assessment of deltamethrin and flufenacet
Toxicology Letters·2024
S05-01 Functional mapping of neurodevelopmental disorders to ontology-based DNT NAMs for Next Generation Risk Assessment of chemicals
Toxicology Letters·2024
Comprehensive mapping of the AOP-Wiki database: identifying biological and disease gaps
Frontiers in Toxicology·2024· 15 citedOpen Access
S03-03: New approach methodologies (NAMs) for developmental neurotoxicity evaluation (DNT) and their use for regulatory purposes
Toxicology Letters·2023
Prediction of in vivo prenatal chlorpyrifos exposure leading to developmental neurotoxicity in humans based on in vitro toxicity data by quantitative in vitro–in vivo extrapolation
Frontiers in Pharmacology·2023· 17 citedOpen Access
Assessment of neurotransmitter release in human iPSC-derived neuronal/glial cells: a missing in vitro assay for regulatory developmental neurotoxicity testing
Reproductive Toxicology·2023· 8 citedOpen Access
The Adverse Outcome Pathway Framework Applied to Neurological Symptoms of COVID-19
Cells·2022· 16 citedOpen Access
Quality criteria for in vitro human pluripotent stem cell-derived models of tissue-based cells
Reproductive Toxicology·2022· 8 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Guy C. Brown(10), Sandra Coecke(10), Thomas Härtung(9), Helena T. Högberg(8), Francesca Pistollato(7), Andrew Worth(6), Susanne Hougaard Bennekou(6), Magdalini Sachana(6), Kevin M. Crofton(5), Florianne Monnet‐Tschudi(5), Ellen Fritsche(5), Alicia Paini(5), Pamela J. Lein(4), Marcel Leist(4), Stephanie K. Bopp(4), Maurice Whelan(4), Andrea Terron(4), Timothy J. Shafer(4), A Kinsner(4), Tuula Heinonen(3)